Norwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each

Deep News

07/28

PHARMARON (ASX: 03759) shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.

The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.

Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1167069371"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167069371\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1167069371?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 07:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167069371","market":"sh","top_or_hot":-1,"title":"Norwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each","media":"Deep News","content":"<p><b>PHARMARON (ASX: 03759)</b> shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.<br><br>The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.<br><br>Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Norwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNorwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-07-28 07:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>PHARMARON (ASX: 03759)</b> shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.<br><br>The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.<br><br>Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ENOR","symbol_name":"iShares MSCI Norway ETF","start_time":0,"source_url":"","article_id":"1167069371","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167069371","pubTimestamp":1785195627,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"PHARMARON (ASX: 03759) shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.The exchange's latest data indicates that on July 23, Norges Bank reduced its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","ENOR":"iShares MSCI Norway ETF","BK0216":"研究试验","BK1141":"生命科学工具和服务","EWH":"香港ETF-iShares MSCI","03759":"康龙化成","BK1576":"医药外包概念"},"translate_title":"挪威主权财富基金以每股约23.63港元减持康龙化成55,200股股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03759":1,"ENOR":1,"EWH":1},"content_text":"PHARMARON (ASX: 03759) shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}